Table 1 ADA-SCID patients naive for... | American Society of Hematology

Table 1

ADA-SCID patients naive for therapy display significantly reduced growth

	Age, y	Percentile height, Z-score	RANKL, pg/mL	OPG, pg/mL	RANKL/OPG, × 10²
Patient no. 1	1	−1.66	1.42	181.9	0.78
Patient no. 2	1.9	−3.91	1.03	129.6	0.79
Patient no. 3	1.8	−1.83	0	181.9	0
Patient no. 4	1.6	−1.90	0	145.2	0
Patient no. 5	0.5	−2.21	3.08	257.3	1.19
ND 1-5 years of age (n = 10), mean (SEM)			11.49 (3)	104.1 (7)	13.4 (5)
P			.005	.003	.011

	Age, y	Percentile height, Z-score	RANKL, pg/mL	OPG, pg/mL	RANKL/OPG, × 10²
Patient no. 1	1	−1.66	1.42	181.9	0.78
Patient no. 2	1.9	−3.91	1.03	129.6	0.79
Patient no. 3	1.8	−1.83	0	181.9	0
Patient no. 4	1.6	−1.90	0	145.2	0
Patient no. 5	0.5	−2.21	3.08	257.3	1.19
ND 1-5 years of age (n = 10), mean (SEM)			11.49 (3)	104.1 (7)	13.4 (5)
P			.005	.003	.011

ND indicates normal donor.